Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H17N |
| Molecular Weight | 175.2701 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1(CCCCC1)C2=CC=CC=C2
InChI
InChIKey=RGZGRPPQZUQUCR-UHFFFAOYSA-N
InChI=1S/C12H17N/c13-12(9-5-2-6-10-12)11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10,13H2
| Molecular Formula | C12H17N |
| Molecular Weight | 175.2701 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of ionotropic glutamate receptor channel blockers on the development of pentylenetetrazol kindling in mice. | 2007-01 |
|
| [Effects of blockade of ionotropic glutamate receptors on the development of pentylenetetrazole kindling in mice]. | 2005-11 |
|
| The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals. | 2003-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:42:00 GMT 2025
by
admin
on
Mon Mar 31 22:42:00 GMT 2025
|
| Record UNII |
HBO2D49I2S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
7460
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID30176449
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
PRIMARY | |||
|
31862
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
PRIMARY | |||
|
2201-24-3
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
PRIMARY | |||
|
HBO2D49I2S
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
PRIMARY | |||
|
DB01506
Created by
admin on Mon Mar 31 22:42:00 GMT 2025 , Edited by admin on Mon Mar 31 22:42:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
|
||
|
PARENT -> METABOLITE |
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
